Logan Stone Capital LLC Takes Position in BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Logan Stone Capital LLC purchased a new position in BlackRock Health Sciences Term Trust (NYSE:BMEZ) in the 2nd quarter, Holdings Channel.com reports. The firm purchased 115,244 shares of the company’s stock, valued at approximately $1,770,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. PNC Financial Services Group Inc. grew its stake in shares of BlackRock Health Sciences Term Trust by 17.7% during the fourth quarter. PNC Financial Services Group Inc. now owns 30,559 shares of the company’s stock valued at $448,000 after purchasing an additional 4,604 shares during the last quarter. Oppenheimer & Co. Inc. grew its position in shares of BlackRock Health Sciences Term Trust by 2.0% during the 4th quarter. Oppenheimer & Co. Inc. now owns 76,699 shares of the company’s stock worth $1,124,000 after buying an additional 1,536 shares during the period. Quantedge Capital Pte Ltd grew its position in shares of BlackRock Health Sciences Term Trust by 47.5% during the 4th quarter. Quantedge Capital Pte Ltd now owns 375,026 shares of the company’s stock worth $5,494,000 after buying an additional 120,800 shares during the period. Karpus Management Inc. raised its stake in shares of BlackRock Health Sciences Term Trust by 27.1% during the fourth quarter. Karpus Management Inc. now owns 1,217,589 shares of the company’s stock worth $17,838,000 after buying an additional 259,464 shares during the last quarter. Finally, LM Advisors LLC acquired a new position in BlackRock Health Sciences Term Trust in the fourth quarter valued at approximately $1,591,000.

BlackRock Health Sciences Term Trust Stock Up 0.4 %

BMEZ opened at 15.79 on Friday. The company has a fifty day moving average price of 15.84 and a two-hundred day moving average price of 15.54. BlackRock Health Sciences Term Trust has a 52 week low of 12.93 and a 52 week high of 16.59.

BlackRock Health Sciences Term Trust Dividend Announcement

The business also recently announced a monthly dividend, which will be paid on Thursday, October 31st. Shareholders of record on Tuesday, October 15th will be paid a $0.176 dividend. This represents a $2.11 annualized dividend and a yield of 13.37%. The ex-dividend date of this dividend is Tuesday, October 15th.

Insiders Place Their Bets

In other news, major shareholder Saba Capital Management, L.P. purchased 27,148 shares of the business’s stock in a transaction that occurred on Tuesday, September 17th. The shares were acquired at an average cost of 15.93 per share, for a total transaction of 432,467.64. Following the transaction, the insider now directly owns 20,565,579 shares of the company’s stock, valued at approximately 327,609,673.47. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Over the last quarter, insiders have purchased 44,909 shares of company stock worth $718,686.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.